List of works - Lyn Guenther

A Treatment Algorithm for Moderate to Severe Atopic Dermatitis in Adults

scientific article

A dose-finding trial with a novel ingenol derivative (ingenol disoxate: LEO 43204) for field treatment of actinic keratosis on full face or 250 cm2 on the chest

scientific article published on 7 March 2017

A multicenter, double-blind, randomized comparison study of the efficacy and tolerability of once-daily tazarotene 0.1% gel and adapalene 0.1% gel for the treatment of facial acne vulgaris.

scientific article published in February 2002

A randomized study comparing the combination of nbUVB and etanercept to etanercept monotherapy in patients with psoriasis who do not exhibit an excellent response after 12 weeks of etanercept

scientific article published on 10 August 2011

A refresher on herpes zoster, current status on vaccination, and the role of the dermatologist

scientific article published on July 2011

A review of common pediatric lip lesions: herpes simplex/recurrent herpes labialis, impetigo, mucoceles, and hemangiomas

scientific article

Acitretin Use in Dermatology.

scientific article published in September 2017

Alefacept is safe and efficacious in the treatment of palmar plantar pustulosis

scientific article published in November 2007

An Open Letter to Health Canada

scientific article published in May 2017

Calcipotriol plus betamethasone dipropionate gel compared with its active components in the same vehicle and the vehicle alone in the treatment of psoriasis vulgaris: a randomised, parallel group, double-blind, exploratory study

scientific article published on 23 April 2010

Canadian hand dermatitis management guidelines

scientific article

Clobetasol propionate shampoo 0.05% is efficacious and safe for long-term control of scalp psoriasis

scientific article published in January 2010

Coma blisters, peripheral neuropathy, and amitriptyline overdose: a brief report

scientific article

Development of a Clinical Pathway for Atopic Dermatitis Patients: A Case-Based Approach

scientific article published on December 2016

Early onset of action and efficacy of a combination of calcipotriene and betamethasone dipropionate in the treatment of psoriasis

scientific article

Efficacy and Safety of Ixekizumab Through 5 Years in Moderate-to-Severe Psoriasis: Long-Term Results from the UNCOVER-1 and UNCOVER-2 Phase-3 Randomized Controlled Trials

scientific article published on 21 March 2020

Epidemiology of immune-mediated inflammatory diseases: incidence, prevalence, natural history, and comorbidities.

scientific article published on May 2010

Fixed-dose combination therapy for psoriasis

scientific article published on January 2004

GRS Nubes Supra Lunam, a New Lunula Shape

scientific article published in November 2015

How Mohs Surgery Transformed Into a First-Line Treatment of Skin Cancer

scientific article published on 5 July 2016

Incorporating biologics into the treatment of psoriasis

scientific article

Integrating biologic agents into management of moderate-to-severe psoriasis: a consensus of the Canadian Psoriasis Expert Panel. February 27, 2004.

scientific article

Kasabach-merritt syndrome

scientific article published on 15 April 2002

Leveraging Blockchain Technology for Informed Consent Process and Patient Engagement in a Clinical Trial Pilot

scientific article published on 14 October 2021

Mise à jour sur la vaccination contre l’herpès zoster: Guide à l’intention des médecins de famille

Non-melanoma Skin Cancer in Canada Chapter 1: Introduction to the Guidelines.

scientific article published on 27 May 2015

Non-melanoma Skin Cancer in Canada Chapter 4: Management of Basal Cell Carcinoma

scientific article published on 18 May 2015

Optimizing treatment with topical tazarotene

scientific article

Pathophysiology of psoriasis: science behind therapy

scientific article

Pathway to dry skin prevention and treatment

scientific article published on January 2012

Patients' Perspectives on the Impact of Genital Psoriasis: A Qualitative Study.

scientific article

Psoriasis and multiple sclerosis: is there a link?

scientific article

Psoriasis comorbidities

scientific article published on September 2009

Psoriatic Nail Changes Are Associated With Clinical Outcomes in Psoriatic Arthritis

scientific article published on 5 March 2015

Review of Systemic Treatment Options for Adult Atopic Dermatitis.

scientific article published on 15 September 2016

Rosacea and atopic dermatitis. Two common oculocutaneous disorders

scientific article

Socioeconomic Burden of Immune-Mediated Inflammatory Diseases -- Focusing on Work Productivity and Disability ⬇️

scientific article published on November 1, 2011

Systematic Review on the Efficacy and Safety of Oral Janus Kinase Inhibitors for the Treatment of Atopic Dermatitis ⬇️

journal article from 'Frontiers in Medicine' published in 2021

Tanning behavior of London-area youth

scientific article published in January 2009

The Coexistence of Psoriasis and Vitiligo: A review ⬇️

scientific article published on September 1, 2012

The burden of psoriasis in Canada: insights from the pSoriasis Knowledge IN Canada (SKIN) survey

scientific article published in September 2009

The influence of uveitis on patients with immune-mediated inflammatory disease.

scientific article

The role of inflammation in the pathophysiology of depression: different treatments and their effects.

scientific article

The use of alefacept in the treatment of psoriasis

scientific article published on 01 August 2004

Understanding and assessing potential serious adverse events: a practical approach to understanding the benefits and harm of psoriasis treatments.

scientific article published on May 2013

Update on herpes zoster vaccination: a family practitioner's guide ⬇️

scientific article published on October 1, 2011

Ustekinumab decreases work limitations, improves work productivity, and reduces work days missed in patients with moderate-to-severe psoriasis: results from PHOENIX 2.

scientific article published on 31 October 2010

List of works by Lyn Guenther

A Treatment Algorithm for Moderate to Severe Atopic Dermatitis in Adults

A dose-finding trial with a novel ingenol derivative (ingenol disoxate: LEO 43204) for field treatment of actinic keratosis on full face or 250 cm2 on the chest

A multicenter, double-blind, randomized comparison study of the efficacy and tolerability of once-daily tazarotene 0.1% gel and adapalene 0.1% gel for the treatment of facial acne vulgaris.

A randomized study comparing the combination of nbUVB and etanercept to etanercept monotherapy in patients with psoriasis who do not exhibit an excellent response after 12 weeks of etanercept

A refresher on herpes zoster, current status on vaccination, and the role of the dermatologist

A review of common pediatric lip lesions: herpes simplex/recurrent herpes labialis, impetigo, mucoceles, and hemangiomas

Acitretin Use in Dermatology.

Alefacept is safe and efficacious in the treatment of palmar plantar pustulosis

An Open Letter to Health Canada

Calcipotriol plus betamethasone dipropionate gel compared with its active components in the same vehicle and the vehicle alone in the treatment of psoriasis vulgaris: a randomised, parallel group, double-blind, exploratory study

Canadian hand dermatitis management guidelines

Clobetasol propionate shampoo 0.05% is efficacious and safe for long-term control of scalp psoriasis

Coma blisters, peripheral neuropathy, and amitriptyline overdose: a brief report

Development of a Clinical Pathway for Atopic Dermatitis Patients: A Case-Based Approach

Early onset of action and efficacy of a combination of calcipotriene and betamethasone dipropionate in the treatment of psoriasis

Efficacy and Safety of Ixekizumab Through 5 Years in Moderate-to-Severe Psoriasis: Long-Term Results from the UNCOVER-1 and UNCOVER-2 Phase-3 Randomized Controlled Trials

Epidemiology of immune-mediated inflammatory diseases: incidence, prevalence, natural history, and comorbidities.

Fixed-dose combination therapy for psoriasis

GRS Nubes Supra Lunam, a New Lunula Shape

How Mohs Surgery Transformed Into a First-Line Treatment of Skin Cancer

Incorporating biologics into the treatment of psoriasis

Integrating biologic agents into management of moderate-to-severe psoriasis: a consensus of the Canadian Psoriasis Expert Panel. February 27, 2004.

Kasabach-merritt syndrome

Leveraging Blockchain Technology for Informed Consent Process and Patient Engagement in a Clinical Trial Pilot

Mise à jour sur la vaccination contre l’herpès zoster: Guide à l’intention des médecins de famille

Non-melanoma Skin Cancer in Canada Chapter 1: Introduction to the Guidelines.

Non-melanoma Skin Cancer in Canada Chapter 4: Management of Basal Cell Carcinoma

Optimizing treatment with topical tazarotene

Pathophysiology of psoriasis: science behind therapy

Pathway to dry skin prevention and treatment

Patients' Perspectives on the Impact of Genital Psoriasis: A Qualitative Study.

Psoriasis and multiple sclerosis: is there a link?

Psoriasis comorbidities

Psoriatic Nail Changes Are Associated With Clinical Outcomes in Psoriatic Arthritis

Review of Systemic Treatment Options for Adult Atopic Dermatitis.

Rosacea and atopic dermatitis. Two common oculocutaneous disorders

Socioeconomic Burden of Immune-Mediated Inflammatory Diseases -- Focusing on Work Productivity and Disability ⬇️

Systematic Review on the Efficacy and Safety of Oral Janus Kinase Inhibitors for the Treatment of Atopic Dermatitis ⬇️

Tanning behavior of London-area youth

The Coexistence of Psoriasis and Vitiligo: A review ⬇️

The burden of psoriasis in Canada: insights from the pSoriasis Knowledge IN Canada (SKIN) survey

The influence of uveitis on patients with immune-mediated inflammatory disease.

The role of inflammation in the pathophysiology of depression: different treatments and their effects.

The use of alefacept in the treatment of psoriasis

Understanding and assessing potential serious adverse events: a practical approach to understanding the benefits and harm of psoriasis treatments.

Update on herpes zoster vaccination: a family practitioner's guide ⬇️

Ustekinumab decreases work limitations, improves work productivity, and reduces work days missed in patients with moderate-to-severe psoriasis: results from PHOENIX 2.